Grant: Collaborative Health Research Projects (NSERC partnered)
McMaster University
$240,625.00
Engineering Starch-Based Nanoparticles and Nanoparticle Clusters for Improving Local Drug Delivery to Tumour Cores and the Brain
FY 2016-17
Summary
Delivering drugs using nanoparticles has been demonstrated in multiple cases to improve the ability of drugs to get to their target sites, particularly in cases in which drugs must be transported inside cells to be functional and/or drug must be transported from the blood through hard-to-penetrate biological barriers (e.g. into the brain or through dense tissues such as tumour masses). Starch nanoparticles (SNPs), developed by our partner EcoSynthetix, have particular potential for drug delivery in this context given their capacity for direct loading of drug during fabrication, their extremely small sizes, their gel-like properties (and thus potential to deform under stress), and their biological inertness. However, there are two inherent limitations to using SNPs for drug delivery: (1) drug release from SNPs is very fast given their porous structures and (2) the small size of SNPs, while ideal for penetrating into the brain or deep into tumours, also induces relatively fast clearance of SNPs from normal circulation, restricting the capacity of SNPs to transport drugs to target sites. In this proposal, we aim to address these challenges by (1) engineering the surface of SNPs to adjust drug release rates to desired values and (2) developing methods of fabricating controlled clusters of SNPs with good circulation properties that can be selectively degraded where drug release is desired (either by specific chemistry at the target site or by external activation after a specific time). We anticipate that such SNP-based materials will significantly improve the delivery of drugs not only deep inside tumours and both into and within the brain (our two proof-of-concept demonstrations) but also other diseases in which effective therapy is limited by drug transport. Such capacity is anticipated to both improve health outcomes for Canadians suffering from such diseases as well as provide a new, value-added market to EcoSynthetix that will promote new job creation in Canada.
Department
Program
Collaborative Health Research Projects (NSERC partnered)
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
361147
Name
Hoare Todd R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
Engineering Starch-Based Nanoparticles and Nanoparticle Clusters for Improving Local Drug Delivery to Tumour Cores and the Brain
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$240,625
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Cancer; Core-Shell Nanoparticles; Drug Delivery; Intranasal Delivery; Nanoparticle; Nanoparticle Clusters; Schizophrenia; Starch; Tissue Penetration; Triggered Release
Abstract
Delivering drugs using nanoparticles has been demonstrated in multiple cases to improve the ability of drugs to get to their target sites, particularly in cases in which drugs must be transported inside cells to be functional and/or drug must be transported from the blood through hard-to-penetrate biological barriers (e.g. into the brain or through dense tissues such as tumour masses). Starch nanoparticles (SNPs), developed by our partner EcoSynthetix, have particular potential for drug delivery in this context given their capacity for direct loading of drug during fabrication, their extremely small sizes, their gel-like properties (and thus potential to deform under stress), and their biological inertness. However, there are two inherent limitations to using SNPs for drug delivery: (1) drug release from SNPs is very fast given their porous structures and (2) the small size of SNPs, while ideal for penetrating into the brain or deep into tumours, also induces relatively fast clearance of SNPs from normal circulation, restricting the capacity of SNPs to transport drugs to target sites. In this proposal, we aim to address these challenges by (1) engineering the surface of SNPs to adjust drug release rates to desired values and (2) developing methods of fabricating controlled clusters of SNPs with good circulation properties that can be selectively degraded where drug release is desired (either by specific chemistry at the target site or by external activation after a specific time). We anticipate that such SNP-based materials will significantly improve the delivery of drugs not only deep inside tumours and both into and within the brain (our two proof-of-concept demonstrations) but also other diseases in which effective therapy is limited by drug transport. Such capacity is anticipated to both improve health outcomes for Canadians suffering from such diseases as well as provide a new, value-added market to EcoSynthetix that will promote new job creation in Canada.
Competitiondate
201610
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Hoare, Todd R; Mishra, Ram K; Wan, Yonghong
Approvedterm
3 ans 0 mois
Cihrcontribution2
Major Initiatives #2~ $240,625~ $0~